Factors Associated with Longer Length of Stay in Recurrent Cellulitis on Lower Legs

  • Vesna Brishkoska-Boshkovski Department of Dermatology, City General Hospital “8th September” Skopje, Republic of Macedonia
  • Mirela Vasileva Department of Dermatology, Clinical Hospital Shtip, Shtip, Republic of Macedonia
  • Marjan Baloski Department of Pulmonology and Allergology, City General Hospital “8th September” Skopje, Republic of Macedonia
Keywords: Length of stay, Recurrent cellulitis, Diabetes mellitus – insulin dependent

Abstract

BACKGROUND: Cellulitis is a common infectious disease with typical feature – the tendency for recurrence.

AIM: The aim of the study was to define comorbidities, clinical, and laboratory – biochemical factors associated with longer length of stay (LOS) in patients with recurrent cellulitis in the lower legs.

MATERIALS AND METHODS: The study is a retrospective-cohort study conducted at the Department of Dermatovenerology at General Hospital in Skopje, from January 2016 to August 2019. In the study, we included and analyzed only hospitalized patients admitted for recurrent cellulitis on the lower legs. Inclusion in the study recorded the following variables comorbid conditions in the patients present in the medical records or obtained from the interview of the patient and initial values of laboratory assays on admission.

RESULTS: The study included hospitalized 205 patients, admitted for recurrent cellulitis. The most significant comorbid conditions and laboratory parameters which correlate with increased LOS are as follows: Type 2 diabetes mellitus insulin dependent (p < 0.001), chronic renal failure (p = 0.003), ischemic heart disease (p = 0.006), peripheral arterial disease (p = 0.007), fever ≥38.0°C (p < 0.001), hypoalbuminemia ˂34 g/L (p < 0.001), elevated value of C-reactive protein >10 mg/L (p < 0.001), and leukocytosis >109 L (p = 0.009).

CONCLUSION: Cellulitis is potential medical emergency event. Recurrence is the most significant complication of cellulitis and lower legs cellulitis is associated with a risk for long-term morbidity. The study has identified several independent factors that are significantly associated with an increased LOS. This independent factors present on admission can stratify the patient with the highest risk of mortality, can improve patient care for better outcomes, and decrease the number of relapses and hospital readmissions.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med. 1996;334(4):240-5. https://doi. org/10.1056/nejm199601253340407 PMid:8532002

Swartz MN. Clinical practice. Cellulitis. N Engl J Med. 2004;350(9):904-12. PMid:14985488

Hay RJ, Adriaans BM. Bacterial infections. In: Burns DA, Breathnach SM, Cox NH, Griffiths CE, editors. Rook’s Textbook of Dermatology. 7th ed. Vol. 1. Oxford: Blackwell Publishing; 2004. p. 16-27.

Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59(2):e10-52. https://doi.org/10.1093/cid/ciu296 PMid:24947530

Mcnamara DR, Tlyjeh IM, Berbari EF, Lahr BD, Martinez J, Mirzoyev SA, et al. A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Intern Med. 2007;167(7):709-15. https://doi.org/10.1001/archinte.167.7.709 PMid:17420430

Pavlotsky F, Amrani S, Trau H. Recurrent erysipelas: Risk factors. J Dtsch Dermatol Ges. 2004;2(2):89-95. https://doi. org/10.1046/j.1439-0353.2004.03028.x PMid:16279242

Goettsch WG, Bavinck JN, Herings RM. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol. 2006;20(7):834-9. https://doi. org/10.1111/j.1468-3083.2006.01657.x PMid:16898907

Phoenix G, Das S, Joshi M. Diagnosis and management of cellulitis. BMJ. 2012;345:e4955. https://doi.org/10.1136/bmj. e4955 PMid:22872711

Christensen KL, Holman RC, Steiner CA, Sejvar JJ, Stoll BJ, Schonberger LB. Infectious disease hospitalizations in the United States. Clin Infect Dis. 2009;49(7):1025-35. https://doi. org/10.1086/605562 PMid:19708796

NHS Digital. Hospital Episode Statistics for England 2014-15. Available from: https://www.digital.nhs.uk/catalogue/PUB19124. [Last accessed on 2017 Apr 09].

Australian Institute of Health and Welfare. Australian Hospital Statistics 2001-2002. Canberra: AIHW; 2003.

Karppelin M, Siljander T, Vuopio-Varkila J, Kere J, Huhtala H, Vuento R, et al. Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: A prospective case-control study. Clin Microbiol Infect. 2010;16(6):729-34. https://doi. org/10.1111/j.1469-0691.2009.02906.x PMid:19694769

Carratala J, Roson B, Fernandez-Sabe N, Shaw E, del Rio O, Rivera A, et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis. 2003;22(3):151-7. https://doi. org/10.1007/s10096-003-0902-x PMid:12649712

Guberman D, Gilead LT, Zlotogorski A, Schamroth J. Bullous erysipelas: A retrospective study of 26 patients. J Am Acad Dermatol. 1999;41(5 Pt 1):733-7. https://doi.org/10.1016/ s0190-9622(99)70009-5 PMid:10534636

Chelsom J, Halstensen A, Haga T, Hoiby EA. Necrotising fasciitis due to group A streptococci in Western Norway: Incidence and clinical features. Lancet. 1994;344(8930):1111-5. https://doi. org/10.1016/s0140-6736(94)90629-7 PMid:7934492

Lazzarini L, Conti E, Tositti G, de Lalla F. Erysipelas and cellulitis: Clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect. 2005;51(5):383-9. https://doi.org/10.1016/j. jinf.2004.12.010 PMid:16321649

Concheiro J, Loureiro M, González-Vilas D, García- Gavín J, Sánchez-Aguilar D, Toribio J, et al. Erysipelas and cellulitis: A retrospective study of 122 cases. Acta Dermosifiliogr. 2009;100(10):888-94. https://doi.org/10.1016/ s1578-2190(09)70560-8 PMid:20038366

Bartholomeeusen S, Vandenbroucke J, Truyers C, Buntinx F. Epidemiology and comorbidity of erysipelas in primary care. Dermatology. 2007;215(2):118-22 https://doi. org/10.1159/000104262 PMid:17684373

Bjornsdottir S, Gottfredsson M, Thorisdottir AS, Gunnarsson GB, Ríkardsdóttir H, Kristjánsson M, et al. Risk factors for acute cellulitis of the lower limb: A prospective case-control study. Clin Infect Dis. 2005;41(10):1416-422. https://doi. org/10.1086/497127 PMid:16231251

Published
2020-05-05
How to Cite
1.
Brishkoska-Boshkovski V, Vasileva M, Baloski M. Factors Associated with Longer Length of Stay in Recurrent Cellulitis on Lower Legs. Open Access Maced J Med Sci [Internet]. 2020May5 [cited 2020Oct.23];8(B):490-4. Available from: https://www.id-press.eu/mjms/article/view/4074